Immunologic recognition of a 25-amino acid
repeat arrayed in tandem on a major antigen of
Blastomyces dermatitidis.
B S Klein, … , L H Hogan, J M Jones
J Clin Invest.
1993;
92(1)
:330-337.
https://doi.org/10.1172/JCI116571
.
A 120-kD glycoprotein antigen abundantly expressed on Blastomyces dermatitidis yeasts is
a target of cellular and humoral immune responses in human infection. To investigate the
antigen and immune response more carefully at the molecular level, we screened an
expression library from B. dermatitidis to identify clones that encode this antigen,
designated WI-1. A 942-bp cDNA was isolated by immunologic screening with polyclonal,
rabbit anti-WI-1 antiserum. Northern hybridization analysis showed that the cDNA
hybridized to yeast message approximately equal to 3.9 kb. DNA and deduced protein
sequence analysis of the clone demonstrated a 25-amino acid repeat arrayed in tandem,
present in 4.5 copies near the 5' end, and rich in predicted antigenic epitopes. Further
analysis showed strong homology in these tandem repeats with invasin, an adhesin of
Yersiniae. Cloned cDNA was used to express a 30-kD fusion protein strongly recognized in
western blots by rabbit anti-WI-1 antiserum, and by sera from all 35 blastomycosis patients
studied. The fusion protein product of subcloned cDNA encoding only the tandem repeat
also was strongly recognized in western blots by sera from the 35 blastomycosis patients,
but not by sera from 10 histoplasmosis and 5 coccidioidomycosis patients. An
antigen-inhibition radioimmunoassay showed that the tandem repeat alone completely eliminated
rabbit and human anti-WI-1 antibody binding to radiolabeled native WI-1. From these
results, we conclude that the […]
Research Article
Find the latest version:
http://jci.me/116571/pdf
Immunologic
Recognition of
a25-Amino
Acid
Repeat
Arrayed
in Tandem
on aMajor Antigen of Blastomyces dermatitidis
BruceS.Klein,*"Laura H. Hogan,* and Jeffrey M.Jonesil
Departmentsof*Pediatrics, $Internal Medicine, and
WMedical
Microbiology and Immunology, UniversityofWisconsinMedical Schooland University ofWisconsinHospital and Clinics; and
IlResearch
Service, WilliamS.Middleton Memorial VeteransHospital, Madison, Wisconsin53705Abstract
A120-kDglycoprotein antigen abundantly expressed on
BWas-tomyces
dermatitidis
yeasts is a target of cellular and humoral immuneresponses in human infection. To investigate the anti-gen and immune response more carefully at the molecular level, we screened an expression library from B. dermatitidis to iden-tify clones that encode this antigen, designated WI-1.A942-bp cDNA wasisolated byimmunologic
screening with polyclonal, rabbitanti-WI-i
antiserum. Northern hybridization analysis showed that the cDNAhybridized
toyeast message_3.9 kb.DNA anddeduced protein sequence
analysis
of the clone dem-onstrateda25-amino acid repeatarrayed in tandem, present in 4.5copies
nearthe5'
end, and rich inpredicted antigenic
epi-topes. Further analysis showed strong homologyinthese
tan-dem repeats with invasin, an adhesin of
Yersiniae.
Cloned cDNA was used to express a 30-kD fusionprotein
strongly recognized in western blots by rabbitanti-WI-i
antiserum, and by sera from all 35blastomycosis
patients
studied. The fusion protein product of subcloned cDNAencoding only
the tandem repeat also was stronglyrecognized
inwestern blots byserafrom the
35 blastomycosis patients,
butnot byserafrom 10histoplasmosis
and5coccidioidomycosis
patients.
Anantigen-inhibition radioimmunoassay showed that the tandem repeat alonecompletely
eliminated
rabbit and humananti-WI-i
anti-bodybinding
toradiolabeled native WI-1. From theseresults,
we conclude that the
25-amino
acid repeat of WI-1displays
animmunodominant
B cell epitope, and that thecarboxyl-ter-minus of the molecule
exhibits
anarchitecture that maypro-moteadhesion of
Blastomyces
yeaststohost cellsor extracellu-larmatrixproteins
andultimately
provide
aclearerpicture
of the molecularpathogenesis
ofblastomycosis. (J.
Clin. Invest. 1993.92:330-337.)
Keywords: blastomycosis * tandem repeataserodiagnosis
*dimorphic fungus * cDNAIntroduction
Blastomycosis,
anendemic
systemic
mycosis accompanied by
protean
manifestations
involving
thelung, skin, bone,
genito-urinary
tract, andbrain,
results from infection with the thermaldimorphic fungus Blastomyces
dermatitidis. Humans andAddresscorrespondencetoDr. Bruce S.Klein, Universityof Wiscon-sinHospitalandClinics, K4/434,600HighlandAvenue,Madison,WI
53792.
Receivedfor publication28August1992and inrevisedform3 Feb-ruary1993.
loweranimals such as dogs are primarily infected by inhaling aerosolized conidia from soil, where the organism dwells as a saprophyte. At
body
temperature, the conidia convert to the parasitic or invasive yeast forms that cause disease.Alack of understanding of the antigens of B. dermatitidis yeasts has hampered the development of reliable assays for diagnosis and study of immunologic features of blastomycosis. We recently described a novel 120-kD surface protein abun-dantly expressed onB.dermatitidis yeasts (1) and have demon-strated thattheantigen isa targetof antibody(1) and
cell-me-diated immune responses in infected humans (2). Based on
theseobservations, we developed a radioimmunoassayto reli-ably diagnose infection by detecting antibody against the pro-tein and havecharacterizedTcellsdirected againstprocessed
forms of the proteininthe course of human disease. Results from these preliminary studies indicatethat the antigen holds
considerablepromise for improved diagnosis and study of the immunologic features of blastomycosis.
Inourinitial work with the 120-kD antigen, which we have designated WI-1, we employed crude techniques to isolate small amounts ofpartially purified protein and provided lim-ited
characterization of
the molecule. In the present paper, we reportthecloning of
cDNA encoding a portion ofWI-1. Inaddition
toproviding
anabundant source ofrecombinant anti-gen and detailed structural information about the molecule,ourwork demonstrates that thecarboxyl-terminus of WI-1 en-compasses antigen-rich, tandem repeats and an immunodomi-nant epitope against which human B cell responses are di-rected.
Methods
Fungi. AmericanType CultureCollection(ATCC)strains60636 and 26199wereusedforthesestudies (ATCC,Rockville,MD). These
repre-sent virulent isolates that have beenassociatedwith human disease. Stock cultures were maintained in the yeast form on 7H10 agar
enrichedwith oleic acid-albumincomplex(Sigma Chemical Co.,St.
Louis,MO)at37°C. Yeasts were grown in Erlenmeyer flasks
contain-ing brainheart infusion(BHI)broth(Difco Laboratories, Detroit,MI)
at370Cinagyrator shakerat120 rpmfor72h.Cellswereharvestedby
filtrationthroughasintered glass filter and washed with saline.
Extraction ofRNA andsynthesisofcDNA. Total RNAwas ex-tractedfromfreshlygrownB.dermatitidisyeastsusinga
phenol-chloro-form technique (3).Diethylpyrocarbonate (DEPC)-treatedwaterand RNAse-free glassware andplasticwarewereusedforextracting, purify-ing,andanalyzingRNA. A 10-gwet-wtpelletof yeastswassuspended
in10mllysisbuffer(0.1MTris, 0.1Mlithiumchloride, 0.01M
dithio-threitol, pH 7.0). The cellsuspensionwastransferredtoaprechilled
metal cannistercontaining 10 ml 0.45-0.50-mm glass beads, 15 ml
phenol-chloroform-isoamylalcohol(24:24:1), and2ml10%SDS. The cannisterwasplacedintoanMSKhomogenizer (BraunBiotechIntl.,
Allentown, PA) fitted withacarbondioxidecoolingdevice andagitated
at2,000 strokes/minfor 30sintervalsbeforecooling. Nearlycomplete
disruptionof cellswasaccomplished afterfive intervals. The chilled
330 B.S.Klein,L.H.Hogan,andJ.M. Jones
J.Clin. Invest.
© The AmericanSocietyforClinical
Investigation,
Inc.0021-9738/93/07/0330/08
$2.00
mixture wascentrifugedat5,000gfor 15 minat4VC.The aqueous layerofeach tubewasextractedtwice withphenoland thenrepeatedly
withphenol-chloroform-isoamylalcoholtoclear the interface
ofprecip-itate. Nucleic acidwasprecipitatedwith100%ethanol,rinsed with 70% ethanol, dried, and diluted and stored in DEPC-treated water at
-70'C.Poly(A)'mRNA wasisolated from whole cell RNA witholigo
(dT) celluloseaffinitycolumns(BoehringerMannheimBiochemicals, Indianapolis,IN)using previouslydescribed methods(4). Composition ofwhole cell RNA andpoly
(A)'
mRNApreparationswasfollowedbyagarosegelelectrophoresis and
OD26&280
wasusedtoestimate RNA concentration andpurity.A20-gwet-wtpelletof B. dermatitidis yeasts strain ATCC 60636yielded50 mg total RNA withOD2W.2go
ratio of 2.17.Affinitypurification of10 mg total RNAyielded - 100Agpoly(A)'mRNA.Gelelectrophoresisof total RNA showed abundant and distinct 28S and 18S ribosomal bands.Poly(A)'mRNA showed little
remainingribosomalRNAandasizerange upto - 14kb.
Startingwith 5 gg poly(A)'RNAfrom strain 60636, first- and second-strand cDNAweresynthesizedusingmurinemaloney leuke-mia virusreverse-transcriptase, oligo(dT)primer,and other reagents and methodsspecifiedinacommercialsynthesiskit(PharmaciaLKB
Biotechnology, Piscataway, NJ). The ends of double-stranded cDNA werefilled in with KlenowfragmentandligatedtoEcoRI/NotI
adap-torswith the sequenced(5'-AATTCGCGGCCGC-3'). SephacrylS-400 spun columns (PharmaciaLKB Biotechnology)were usedtopurify
cDNAfragments>400 bp. Eachaliquotof cDNAwasligatedinto 100 ngof a dephosphorylatedphagemidvector,pBluescriptII
(KS')
(Stra-tagene, LaJolla,CA),which containstranscriptionalandtranslational
startsequences from thelacZ gene. Afterligation,cDNAwas
electro-porated into competent Escherichia coliXL1-Blue(Stratagene),which wereprepared asdescribed (5).
Screening the cDNA expression library withantibody and colony hybridization. TransformedE.coliwereplatedon LBagarin 150-mm-diameterpetri plates (Falcon Plastics, Cockeysville, MD). After
over-night growthat37°C, bacteria werereplica-plated onto afresh agar plate, andonto a 150-mmnitrocellulose sheet(Schleicher&Schuell,
Inc., Keene,NH).After coloniesgrewto1-2mmonnitrocellulose,the filterwastransferredto afresh LB agar plate supplemented with 5 mM
isopropylthiogalactoside
(IPTG)'
andincubated foranadditional 2-4 hours. Bacteriaonthefilterswerelysed and the filters processed forimmunoscreeningasdescribed (6). Rabbit antiserumspecificforWI-I (anti-WI-I titer,1:10,240,asmeasuredbyradioimmunoassay [1])was
usedto screen aportionoftheexpression library.Theserum was preab-sorbed with E.coli lysate(PromegaBiotec,Madison, WI) overnightat
4°C.Preliminary experiments determinedthatpreabsorbed antiserum diluted 1:2,000coulddiscriminate50 ng WI-I spottedonto
nitrocellu-losefrombackgroundstaining oflysedE.coli proteinsonthefilter. Immunoscreeningwasperformedwith thisantiserumaccordingto pre-viously described methods (6). Rabbitanti-WI-I bound to nitrocellu-lose was detectedwith goatanti-rabbit immunoglobulin G conjugated with alkaline phosphatase (Promega Biotec). Positive colonies were isolated from original replica plates, replated, and rescreened with
anti-bodyuntil theywerepurified.
A 942 bp WI-l-cDNAidentified through immunoscreening was usedsubsequently to screen the library by colony hybridization to at-tempttoidentify additional,longer cDNAs. The entire 942-bp
frag-ment wasremovedfrom the vector by digestion withNotI(Bethesda ResearchLaboratory, Gaithersburg,MD), andpurified from low
melt-ing point agarose (Bethesda Research Laboratory) using Geneclean (BIO 101, Inc.,LaJolla, CA). A 100-ngaliquot of the fragment was radiolabeled with
[a-32P]dCTP
toaspecificactivityof109
cpm/ug usingrandomoligonucleotidesasprimers (IBI-Kodak Co. New Haven,CT). Colony hybridization was performed as described (6). Positive colonies were isolated from original replica plates, replated, and re-screenedwith probe until they were purified.
Northernhybridizations. Total RNA samples (20
Ag)
wereelectro-1.Abbreviation usedinthis
paper: IPTG,
isopropylthiogalactoside.
phoresed through 1% agarosegelsinMOPS/2.2Mformaldehydefor
16-18 h at 30 V and transferred by capillary action to Nytran
(Schleicher&Schuell, Inc.)membranesusing lOX SSC. DNA
frag-mentsforhybridizationwereradioactivelylabeled with[a-32P]dCTP using random oligonucleotides as primers (IBI-Kodak Co.). WI-i cDNAprobewasobtainedasdescribed forcolony hybridization.An actin DNAprobefromHistoplasma capsulatumwasthe generousgift
of E.Keithandwasusedto assessloadingvariation. RNA molecular
weightmarkerswerepurchased from BRL-Gibco.Probeswere
hybrid-izedtofilters in 40% formamide forhighstringencyor20% formamide for lowstringency,0.25 MNa' (P04),1 mMEDTA,7% SDSat420C for 16-24 h. Hybridizedfilterswerewashed first in2x SSCatroom
temperaturefor2-5min,then in 0.25 MNa'(P04),1 mMEDTA,2% SDSat640Cforhigh stringencyor550Cfor lowstringencytwice for 10 min,nextin 0.04 MNa' (P04),1mMEDTA,1% SDSat640C forhigh stringencyor550C forlowstringencyoncefor 40-60min,andfinally
rinsed in 4x SSCat roomtemperature(7).Washed blotswereusedto
expose XAR-5film,EastmanKodakCo.,Rochester,NYwith
intensi-fyingscreens at-80'C.
Sequenceanalysis. Single-stranded anddouble-strandedplasmid sequencingwasperformedaccordingtotheprotocolssupplied usinga
Sequence2.0 polymerasekit(UnitedStates Biochem.Corp.,
Cleve-land, OH).Single-strandedDNAwaspreparedfrompKS+phagemid
clonesbystandard methods(8). Sequenceprimers homologoustothe
pKS+ vectorpolylinkerweretheT3 and SKprimers (UnitedStates Biochem.Corp.). Three setsofprimers homologousto internal
se-quences in the cDNA insertwerepurchased from Operon
Technolo-gies,Inc.(Alameda,CA).Thecompletesequenceofboth strandswas
determined. Both nucleotide sequences and the derived amino acid sequenceswere usedtosearch the GeneBank and EMBL databases
usingprogramssupplied bytheGenetics Computer Group(8).
Expressionandimmunologicassessmentoffusionprotein.
Trans-formedE.coliwasgrown in LBmediacontaining
50Mgg/ml
ampicillinand 12.5 ,g/mltetracycline inagyrator shakerat 37°C. Whenthe
density ofthe culture reached
OD6w
_0.6(after - 4hofgrowth), 5mMIPTGwasadded.Optimal lacZ geneexpressionandproduction
of the fusion proteinwasexaminedat i-hintervalsafterinduction. Bacteriawerecentrifugedat5,000g for 15 minat4°C.Alysatewas
prepared byresuspendingthepelletin IXgelloading buffer (50mM
Tris, pH 6.8, 100 mMdithiothreitol,2%SDS,0.1%bromphenol blue,
10%glycerol)equivalentto0.1 voloftheoriginalculture. Thelysate
washeated to100°Cfor 3 min andcentrifugedat12,000 gfor1 min at
roomtemperature.LysatesofE.coli containingvectoralonetobe used
as antigen inhibitors of antibody binding in radioimmunoassays
(RIAs)were prepared without reducingagents. Bacteriawere
resus-pended 1:4(wt/vol) in alysis buffer (50mM Tris, pH 8.0, 1 mM
EDTA, 100MuMPMSF,and 10%sucrose)towhichlysozyme (1mg/ml)
andTriton x-100(0.1%)wereaddedbeforecentrifugationat12,000g for 30 min.LysateswereexaminedbySDS-polyacrylamide gelas de-scribedby Laemmli (9).Gelswerestained forproteinwith Coomassie
brilliant blue.
Toassessantibody recognition ofthefusionprotein,westernblots
of gelswerepreparedasdescribed(10).Humanantisera used in these
experimentswerefrom blastomycosis patientsin whomantibody
re-sponsestoWI-i hadpreviouslybeen demonstratedbyRIA(1),and from seronegativecontrol subjects with otherfungal diseasesor no
illness.Sera had been storedat-70°Cforup to8 yprior to testing. Thefusion proteinwaselectroelutedfrompolyacrylamidegels
us-inganelectrophoretic concentrator(Isco, Inc., Lincoln, NE) as de-scribed(1)for furtherimmunologicstudies. To determine the relative
importanceofimmunologic determinantsonthefusionprotein,an
antigen-inhibitionRIA wasused. Itexamined theabilityof samples of elutedproteinorcrudeE.colilysatetoblock anti-WI-Iantibody
bind-ingtoradiolabeled WI-1.Briefly,RIAs were constructedusing 0.1-5ng radiolabeled WI-I as atarget. Assays were done in 12X75mm acid-washed glass tubes. We used0.1%BSA in 0.04 M Na phosphate, 0.15
consisted of 0.1 ml ofdiluted serum and 0.1 ml of radiolabeled antigen. When anantigen-inhibition RIA was done,0.1 mlof the inhibitor or BSA-PBS wasadded todiluted antibody in appropriate tubes. All tubes wereincubated 4-18 h at40Cbefore radiolabeled antigen was added. Foreachantigen-inhibition RIAperformed,a preliminaryRIAwas
done todetermine the dilution of serum that bound - 50%of
radiola-beledantigentarget. This dilution of serumwasadded totubesofthe
antigen-inhibition RIA. For RIAs andantigen-inhibitionRIAs, 2 mg insoluble staphlococcalproteinA(Sigma ChemicalCo.) was added to each sample and control tubeafter overnightincubation at 4VC.
Precip-itates werecentrifuged at 2,000 g for 10-40 min and a volume of super-natant wasremovedfromeach tubeforcountinginagamma counter. Wecorrectedforcoprecipitationin RIAs by the methodofMindenand Farr(1 1).
Results
GGATCCATATCATGAGAAGTATGATTGGGATCTCTGGAATAAGTGGTGCAACAAGGACCC 60
D P Y H E K Y D W D ... 20
Invasin-CTACAACTGCGACTGGGACCCATCTCATGAGAAGTATGATTGGGATCTCTGGAATAAGTG 120
Y ii g ii " a. S H E K Y D W D
like Invasin
-GTGCAACAAGGACCCCTACAACTGTGACTGGGACCCATATCATGAGAAGTATGATTGGGA 180 like
TCTCTGGAATAAGTGGTGCAACAAGGACCCCTACAACTGTGACTGGGACCCATATCATGA
:., .... ....'.. ...K: Y H E
Invasin-like
240
80
GAAGTATGATTGGGATCTCTGGAATAAGTGGTGCAACAAGGACCCCTACAACTGTGACTG 300
K Y D W D . ... 100-W : :
Invasin- like
*
GGACCCATCTCATGAGAAGTACGATTGGGATCTCTGGAGTAAGTGGTGCAACAAGCACGA 360
.nl.w S H E K Y D W D L W S K W C N K H D 120
CGAGCACGACAAACATCCATTGTGCCCTGTCTGTGACCCCCTCTCAGGCAAAAATCACTG 420 E H D K H P L C P V C D P L S G K N H C 140
Identification
of
WI-IcDNAclones. Approximately106 recom-binants were obtained in theexpression library. Rabbit anti-WI-1 antibody was used to screen 2,000 recombinants andidentified twopositiveclones. The cDNA inserts inplasmids from these clones were estimated to be approximately 700 and 950 bp by NotI digestion of the plasmids; EcoRI digestion
yieldeda commonfragment of approximately 430 bp. Colony hybridizationwasusedto screen anadditional 10,000
recombi-nants and identified an additional 25 independent, positive
clones. NotI
digestion
demonstrated each cDNAtobe 950bp and contain thecommonenzymerestriction site for EcoRI. Northernhybridizations usingWI- 1 cDNA toprobeB.
der-matitidis RNA illustrate that the full-length message forWI-1
is - 3.9 kb(Fig. 1). WI- 1 messageis abundantly expressedin
the yeast strain 60636, from which the partial cDNA was
cloned, as well as in the unrelated strain 26199 (data not
shown).
WI-IcDNA sequence. DNA sequenceanalysis ofthe largest
clone isolated by immunoscreening is shown in Fig. 2. The
942-bpsequencecontainstwoopenreadingframes. One open
reading
framepredicts
an amino acid sequenceconforming
verycloselywith theamino acidcomposition
ofWI- 1 incon-taining
largeamountsofcysteine, tyrosine,
andproline (Klein,
B.,
manuscript
inpreparation).
Thepredicted
molecularmassof the recombinant antigen is 25.5 kD; 3.5 kD encoded by
Figure 1. WI- 1 gene
ex-pression
inBlastomyces
dermatitidis yeasts.4111 Northernanalysisof total RNAhybridization
(20,ug)from ATCC strain 60636probed
witha942-bp WI-l
cDNAfragment (lane
2).Ethidium bromide
stainingof gelpriorto
transfer shows28Sand
18Sribosomal bands
(lane3). Molecular size 3, standardsareshown in 2
z o lanei.
TCATCCAACCACTTCCTGTGTCAGCACAGGCCACCACTACCACTGCGCCTGCCGCGCTGG 480 H P T T S C V S T G H H Y H C A C R A G 160
CTACAAGGCTAGCCATTATAGCCATGACCACAAGCATTTCCGCATGCCAGTCAAAGGCTA 540 Y K A S H Y S H D H K H F R M P V K G Y 180
TGAATTCCTTGTTTTCACCGGCCCGCATACCAAGTGCAATGTCCTTTGCGACGGTTACCC 600 E F L V F T G P H T K C N V L C D G Y P 200
GCACAAGCCAGCCCATGAGCTTTGCGGCGAGGTTAAGGTTCATAATTATTGCGGGCCATG 660 H K P A H E L C G E V K V H N Y C G P 219 AGCTTCCTTTGAGGGAAAGCGCAGAAAGAGGGAAATTTGGGGTGATTTTGGAGTACTTGA 720 ACAGATTTATTTTCCTCGTTTTGAGGGAGGGAGAAAGCGAACATGTAATTTTGTAGATGG 780
GTGGAAAGCTTCATCTGACCTCTGGACGAGGTCATTTTTTCCCTTTTATTATGGATAAAT 840 ATTGATGAAGTTGGATAATAGGGAGACATCTTTTTGCAAAATTAATAGTTATATATATGA 900
GTTAGATTACCTTCTTAATTAGATGCTTTAATGATTTTTGTG 942 Figure2.Nucleotideandpredicted proteinsequence ofpartialcDNA
encodingWI- 1.Thepredicted proteinsequenceisindicated below thenucleotidesequence.Numberingtotherightindicates the
nu-cleotideandproteinpositions.The25-aminoacid repeatsarrayedin
tandem,present in 4.5copiesnearthe 5'end,areoverlined witharrow
bars. WI- 1 sequenceshowingsimilarity with invasinappears shaded. Theasteriskoverlyingnucleotideposition359 denotes theFokI re-striction site usedto cutand subclone cDNAencoding onlythe
tan-dem repeats.Apolyadenylation site,located in the 3' nontranslated
region, is comprised ofthetripartatestructure TAGT(nucleotides 886-889),anupstream sequence TAG(859-861)andadownstream sequenceTTT(927-929).This issimilartothepolyadenylationsite
describedfor the CYC 1 gene locus inSaccharomycescerevisiae(29).
plasmid j3-galactosidase
fusionsequences and the remainderby
theWI- 1 insert. TheDNA sequence
predicts
anamino acid sequencecomprising
a 25-aminoacidrepeatarrayed
intan-dem, present in 4.5 copiesnearthe 5'end, withamino acid
variations in onlytwo
positions (serine
vs.tyrosine,
residues3,28,53,78,103;andserine for
asparagine,
residue113).
DNAanddeduced amino acidsequencesofWI-1 showedsimilarity
toothersequences in the GeneBank database(Fig.
2and
3).
17amino acid residuesofWI-1
spanning
the endofonetandem repeat and the
beginning
of another showed35%iden-tity and 88%
homology
totheprotein
adhesion ofYersiniae, invasin(12). 36 amino acid residues outside the tandem repeat ofWI- 1(spanning
nucleotides 391 to498) comprise
acysteine-richregion
showing
27%to41%identity
andahigh degree
ofsimilarity
to anEGF-like domainexpressed
on numerouspro-332 B.S.Klein,L. H.Hogan,and J.M.Jones
kB
7.5-4.4-*
2.4
-4Al
A WI-1 LWNKWCNKDPYNCDWDP Figure 3.Homology of
Invasin LWGEWGS LTAYSSDWCS WI-1 sequencewith other sequences in the
B WI-1 CDPLSGKN-HCHPTTSCVST GenBankandEMBL
EGF Consensus C--L--N N G GCSO -X C X N T data bases.InA andB,
* sequenceidentity is
in-GHHYHCACRAGYKASHY.... dicated byavertical
XGGYXCXCXEGYXLXDGKxcx line.A conservative
F aminoacid substitution
is indicated by a colon. Asteriskscorresponding to EGF consensus sequence denote the pres-enceandspacing of cysteine residues, a prominent feature of the motif.
teinsthatconfer adhesion to cells or extracellularmatrix(13). This similarity with EGF-like domains expressed in at least sevenotherproteins isnotlikelydue tochancealone (P values
ranging from< 1.7 X 10-8 to < 0.01),accordingto a recently
describedalgorithm (14).
Thepredicted structure and antigenicity of the protein en-coded by the WI- 1 insert was analyzed using algorithms of Chou andFasman(15) and KyteandDoolittle (16).The
pro-tein, which corresponds to the carboxyl terminus, is hydro-philic alongmostof its lengthexceptin theportion showingan
EGF-likedomain,inwhichthe moleculeexhibitsa
hydropho-A
B
Mr(kD)'
116-
84-
58-
48.5-
36.5-bF, .
-VW W
...
4o__ l_
66-
45-
36-29-
424-
20-bic region. Residues in this area are predicted to form a beta-pleated sheet, a common structuralmotif of EGF-like domains
based on conserved sequence and dictated by the position of the disulfide bonds (13). In contrast, residues in each region
showing similarity with invasin arepredictedtoform several turns and anahelixat theinitiation. The 25-amino acid repeat
arrayedintandem folds back on itself severaltimes,and these repeats, which also encompass the invasin-like domains, are packedwithpredicted antigenic sites.
Expression of the fusion protein. Lysates of E. coli XLl-blue transformed withthe pBluescriptII vector alone orthe
vector plus 942-bp WI- 1 insert, studied by SDS-PAGE, show that a fusionprotein of - 30 kD is expressed by 2 h and
pro-ducedmaximally by4 hafterinductionwith IPTG(Fig.4 A, lane2, see arrow). This protein may represent WI-1 cleaved from the 3.5 kD (3-galactosidase fusion partner, since the same
lysatealsocontainssmaller amountsof33.5 kDproteinthatis
enriched in comparisonto control lysates. Rabbit anti-WI- 1 specifically recognizes both of these proteins in a western blot
(Fig.
4B).
Human immune responses to WI-Ifusion proteins. 46 sera
from35patientswithculture-confirmedcasesofblastomycosis
were testedfor recognition of proteins inthe E.colilysates. 19
(54%) ofthepatientshad isolated pulmonarydisease, the
re-mainderhaddisseminated disease involving skinalone(8
pa-tients); lungandskin (5); lung,skin,andbrain (1); brainalone (1); and eye alone (1).Titersof antibodyto WI- 1 inthese pa-tients ranged from 1:100 to 1:34,000 (geometric mean titer,
1:850).Allsera testedreactedspecifically withWI- 1 fusion pro-teininWestern blots(Fig. 5).Somebackground reactivitywith E. coli proteinsin the lysatesisseen in alllanesoftheblots.
Preabsorption of rabbit and human anti-WI-1 antisera with either the elutedfusion proteinorwithE.coli lysatecontaining
the fusion protein nearly eliminated recognition of radiola-beled WI- 1 in the RIA, whereas preabsorption with E. coli
lysate without the fusion protein had no influence on WI- 1
recognition (Fig.6, A and B). Thefusion protein further inhib-ited anti-WI-1 bindingto '251-WI-1 inadose-dependent man-ner(Fig.6,
C),
with2 ugprotein inhibiting100% of bindingbyeitherrabbitorhumanantiserum.
30
kD-
14.2-1
2
3
4
Figure4. SDS-PAGE analysisof recombinant
WI-l
protein. (A) 10% acrylamidegel of E. coli lysatecontainingpBluescript II plasmid alone(lane 1) or plasmid plusWI-I cDNAinsert (lane 2) 4 hafter induction with IPTG. Molecular weight standards are indicated to theleft of lane1.Coomassie bluewasusedtostain gel. (B) Immuno-blots of E. coli lysatescontainingplasmidalone(lane 3) orrecombi-nantWI-I (lane 4) probed with rabbitanti-WI-i antiserum (RIA
titer, 1:10,240)diluted 1:2,000. Molecularweightstandardsare indi-catedtotheleftof lane 3.
12 3 4 5 6 7 8 9 10 11 12131415 16
Figure 5.AntibodyrecognitionofrecombinantWI-I inblastomycosis
patients.ImmunoblotsofE.colilysatescontainingrecombinantWI-I (lanes1-8)or vectorcontrol(lanes9-16)4hafter induction with IPTG, probed with antisera fromblastomycosis patients. Serawere
diluted 1:1,000.Resultsareshownfor 8patients(similarresultswere
Mr(kD)
66-
45-
36-
29-
24-
30-
20- $J,_~.f':-.i,<.:.-N
14-2
116- w
-_. .s,. !
S... w.
t .: :: w ..:M
'%.;: '.
...
:
...
.:: .A,
*S,
*: .:
.:iiS
.x... .:.::.,s
S
Ev,X,:
_E _|:
3
B
1
0
c
a 3
E.CaII E.ocll 30 kD Neilve
Yeat yseatY Fusion Wil1
*30kD Protein
Fuslon
Protein
C
100
80~~~~~~~~~
80o
-I*
...
...Z0
ac 40 0 20
0.125 0.250 0.500 1.000
30 kD Fusion Protein(g)
2.000
Figure6. Human and rabbitantibody recognitionof recombinant
andnative WI-Iby radioimmunoassay.An RIAinhibitiontest
mea-sured inhibition ofantibody bindingto 23I-WI-Ibyvariousantigen preparations. (A) SDS-PAGE gelsofantigensusedasinhibitorsinthe
assay:representative E.coli lysatecontaining plasmidvectoralone
(lane 1), electroeluted30-kD recombinantWI-I (lane 2),and
HPLC-purifiednative WI-I (lane 3).(B)Inhibitionofantibody
bind-ingto 1251-WI-l by E.colilysate (50ggprotein),E. colilysate "spiked"withelectroeluted recombinantWI-1 (2ugof fusionprotein
addedtolysate),electroeluted recombinantWI-Ialone(2ggprotein), and nativeWI-1(500 ng). (C) Dose-dependentinhibition ofantibody bindingto1251-WI-l byelectroeluted 30-kD recombinant WI-1.
Dilu-tions of human andrabbit antiserayielding50%radiolabeledantigen bindingwereusedin theassays.
Subcloning
andimmunologic study of the
tandem repeat.We examined whether the tandem repeat of cloned WI-1 cDNAwasanimportantsiteforanti-WI-I antibody
recogni-tion. Restriction sitesbounding therepeatswereusedto sub-clone a 372-bp fragment encoding 4.5 copies ofthe tandem
repeatinto pBluescript II (Fig. 2).AFokIdigest ofWI-I cDNA
yieldeda 1,678-bpfragment including the tandemrepeatsplus
five additional basesatthe3'end andaportion ofvector atthe
5'end. Afterthe endsweremade blunt with Klenowtreatment,
a HindIII digest, which cuts in the polylinker site of pBlue-script,wasusedto separatethe cDNA andvector.The372-bp
fragment was purified and cloned directionally into
pBlue-scriptIIcutwithHind III and SmaI.Ligated cDNAwas
elec-troporated into E. coli XL-I Blue and the transformantswere
assessed for recombinants by blue/white color selection. Fu-sion protein encoded by subcloned cDNAwasexpressedinE.
coliasabove. When studied by SDS-PAGE, the fusion protein
comprised by tandemrepeatsis produced maximally by 4 h
afterinductionwithIPTG,migratesat 21kD,andis
recog-nizedspecifically by rabbit anti-WI-I antiserum inaWestern
blot (Fig. 7).
Serafrom the 35 blastomycosis patients studied abovewere
examined for recognition of the tandem repeat by Western
blot.All ofthem reacted strongly with the recombinant protein
(Fig.8).Noneof theserafromtenpatientswithhistoplasmosis
(complement fixation titers, 1:32to1:512; median titer, 1:128)
orfivepatients with coccidioidomycosis (complement fixation titers, 1:32to1:64; median titer, 1:64) reacted with the
recombi-B
A
Mr
(kD)
45-
36-29-
6.0
24-
20-....
if
14O-
66-
45-
36-
29-
24-i_
_.0-4
",_0
2_
~~Oiz
_ _,*....
1
2
3
4
5
Figure7. Fusionproteinproductof subcloned372-bpWI-I cDNA
encodingtandem repeat.(A) 12.5%SDS-PAGEgelofE.colilysate containingpBluescriptIIplasmidalone(lane 1), plasmid plusWI-I cDNA insert(lane 2)4 h after induction withIPTG,andelectroeluted
fusionprotein (lane 3).Molecularweightstandardsareshown to the
left of lane 1. Coomassiebluewasused to staingels.(B)Immunoblots
ofE.colilysate containingrecombinant WI-I tandemrepeat(lane
4)orplasmidalone(lane 5) probedwith rabbit anti-WI-I antiserum
(RIAtiter1:10,240)diluted 1:2,000.
334 B.S.Klein,L. H.Hogan,and J.M.Jones
1 2 3 4 5 6 7 8 9 10 11 12 13 15 1718 192021 22 3242526
Figure8.Antibodyrecognitionof recombinant WI- I tandem repeat in blastomycosis patients and control subjects. (A) Immunoblots of E. coli
lysatescontaining WI-I tandem repeat (lanes 1-11) probed with antisera from blastomycosis patients. Sera were diluted 1:50. Results are shown forI I representativepatients (similar results were obtained for an additional 24 patients). (B) Immunoblots of E. coli lysates containing WI-I
tandem repeatprobed with antiserafrom 10 histoplasmosis patients (lanes 12-21) and five coccidioidomycosis patients (lanes 22 to 26). Sera were diluted 1:50.
nantprotein,althoughsomebackground reactivitywith E.co/i
proteinsinthelysatesis evident(Fig. 8).
To assess the relativeimportanceof the tandem repeatin
antibody recognitionof WI-1,we testedthe21-kD fusion
pro-tein in the antigen-inhibition RIA using anti-WI-I antisera
from tenblastomycosispatientsand an immunized rabbit.The tandem repeat inhibiteda mean of 96%(range85-100%)ofthe
antibody binding to radiolabeled WI-I in theblastomycosis patients, and87% of thebindingofantibody inthe immune
rabbit
(Fig.
9).The resultswereuninfluenced bywhether thefusion protein was tested after purification by elution,orinthe presence of E. colilysate, whereas E. colilysate alone without the fusionprotein hadnoinfluence whatsoeveronanti-WI-I antibody binding of radiolabeled WI-1.
Discussion
The diagnosis and basic investigation ofblastomycosis has beenseriously hamperedbythe lack ofwell-defined antigens. Werecently described a novel antigen,WI-1,a 120-kD glyco-protein that is abundantly displayedonthe surfaceof B.
der-I I I
EL-n E-.oi 21kD
lysate lysate Fusion
+21kD Protein
Fusion Protein
-*Rabbt Ab tHumanAb
0 %
Pt.1 Pt.2 Pt.3 Pt.4 Pt.5 Pt.6 Pt.7 Pt.8 1t9 Pt.10
21 kDFusion Protein(Tandem repeat)
Pt.10
Naive
W)91
Figure 9. Human and rabbit
antibodyrecognition of combinant WI-i tandem re-peatbyradioimmunoassay.
AnRIAinhibition test mea-suredinhibition of antibody
bindingto '25I-WI-1 by
variousantigen preparations.
Antigensused asinhibitors were: crude E. colilysate containing plasmid vector alone(see Fig. 7, lane 1), electroeluted recombinant
WI-l tandem repeat (seeFig.
8,lane 3), thelysateand eluted proteinpreparations
combined,and HPLC-puri-fied native WI-I (seeFig.7, A, lane3).Protein content of
inhibitorswere50ug crude E.coli lysate,2gg
recombi-nantWI-I tandem repeat, and 500 ng native WI-i.
Di-lutionsofrabbitand human antiserayielding50% radio-labeledantigen binding were used in the assay.
100
80f
- 60
' 40
20
matitidisyeasts(1), shedintothemedium of activelygrowing
cells (Klein, B., manuscript submitted for publication) and
highly conserved in
wild-type
strains(1). Theinteraction ofB.dermatitidis yeasts with the human immune system elicits a vigorous humoral and cell-mediatedresponsedirected against
WI- 1andits
epitopes
during acquisition ofresistanceto infec-tion (1, 2). Because of the possible importance ofWI-l
withrespect toimprovedserodiagnosis,studyofhost-pathogen
in-teractions, and
understanding
of the biology of thefungus,wehave soughttolearnmoreaboutthis antigenatthemolecular level.
Inthis report, wedescribe the cloning of cDNA that
en-codesaportion
of
WI-1.Several lines of evidencesupportthisconclusion.
First, rabbit
anti-WI- 1antiserum
was used to screen anexpressionlibrary for clones that produce immunore-activeprotein,
and the cDNAisolated and characterizedpro-ducesa
fusion
protein
thatreactsspecifically
andstronglywithrabbit antiserum
in bothaWesternblot and radioimmunoas-say. Second,antisera from blastomycosis patients
withhigh
antibody
titerstonative
WI-1 also reactstrongly andspecifi-cally with the fusion
protein
in both of these assays,whereassera
from
15histoplasmosis
orcoccidioidomycosis
control subjects donot.Although the number of controlsstudied
here is limited, the specificity is consistent with previous work, in whichonly two (3%)of 73 control subjects withotherfungal infections had detectableantibody
toradiolabeled,
nativeWI-1(1). Third, the resultsof analysis of the DNA sequence and deduced amino
acid
sequenceof
the cDNA are remarkablyconsistent with
previous analysis
of the amino acidcomposi-tion
of
nativeWI-1, suchasthehigh
contentof
aromatic resi-dues andespecially
theunusually
large amount ofcysteine
(Klein, B.,
manuscript
inpreparation).
Finally,
northernhy-bridization
using
the cloned cDNAprobe identifies
amessage- 3.9 kb,
approximately
thesize
predicted
fornative
WI- 1.Despite
theselines ofevidence,
formalproof
thatwehaveiso-latedWI- 1 cDNAawaitsa
comparison
of the DNA sequencewith amino acidsequence from native WI-1. In view of this
fact,
itmaybeappropriate
torefertothecDNAandrecombi-nant
protein
wedescribeas a WI-1-like
antigen
sequence.ThecDNAclonestudied encodes onlyaportion ofWI- 1.
The
uniformity
in size of about Ikbfor nearly all theindepen-dently
derived cDNA clones isquite striking,
andsuggeststhatRNA secondary structure may interfere with
transcription
beyond this
point.
This conclusion issupported by
previous
difficulties
wehave had with in vitro translation of heat-dena-turedBlastomyces
total orpoly
(A)'
mRNA:Methyl mercury
hydroxide denaturation
ofRNAsecondary
structure wasre-quired
toproduce
large
(although
stillincomplete)
translation
products
(Klein,
B., and J. Jones,manuscript
submitted forpublication).
Secondary structure commonly interferes with thecloning
offull-length
cDNAs(6,
17).
Preliminary
evidence hasindicated thatwe canuse a customprimer
derived from theWI- 1cDNA sequence, rather than
oligo
(dT)121,8,
totranscribe beyond the presumed,problematic
areaof secondarystructureandisolate
larger
cDNAs.The truncatedform of recombinantWI- 1produced bythe
clonedcDNA appears to be
highly antigenic
and tocontainanimmunodominantregion for antibody recognition by infected humans.The fusion protein contains219amino acidsat the
carboxy terminus ofWI- 1.Chou-Fasman
predictions
basedonthe deduced amino acid sequence ofthe fusion
protein
(15)
indicate that the 25-amino acid tandemrepeat is richin
anti-gens, probably B cell epitopes. These predictions are based
principallyonthehydrophilic character,andexposedand
ac-cessiblehighlycharged and polar residues,that appear to
com-prise theturnsandahelices within thisrepeat.Ourresults with
human anti-WI- 1 antisera are consistent with these
predic-tions. All patients tested strongly and specifically recognized the fusion
protein
in Western blots, and nearlyall antibodyreactivity against
WI-1 couldbe removedfromantiserum bypreabsorption with the fusion protein in theRIA.Our
experi-mental results
further
delineate the antibody recognitionsite towithin the tandemrepeatofthefusionprotein.Precise
identifi-cation of the residues that
comprise
theepitope shouldberela-tively straightforward
with thepreparation
of syntheticpep-tidesordeletionmutantsofWI-1 cDNA.
The themeof
immunodominant
Bcellepitopes contained withinmultiplerepeatsarrayedin tandemonmicrobial anti-genhaspreviously
beendescribed inaconservedantigenicepi-topeof
Trypanosoma
cruzi(18)
and in thecircumsporozoite
antigen
ofPlasmodiumfalciparum
(19).
Theimportance of
thestrong immuneresponse
directed against
thesedeterminantsremains
unclear. Nonetheless, identification oftheimmuno-logic importance
of the tandem repeat on WI- 1 will permitimproved
serodiagnosis
of blastomycosis. This issuenotwith-standing,
it is wellaccepted
thatantigen-specific
Tcellsconferacquired
resistance and protectagainst
a lethal challenge ofBlastomyces
inanimal models(20).
We have recently shown thatacquired
resistance in human infection is associated withdevelopment
ofWI- 1-responsive
Tcells. Further studyof
the tandemrepeatand theproducts of larger
orfull-length
cDNAs ofWI-1 willpermit identification
ofTcellepitopes.Anexamination of theDNAanddeducedaminoacid se-quence
of
WI-1offers potentially
informativeinsights into
anabundantly expressed,
highly
conserved molecule of Blasto-myceswhosefunction is unknown. The deduced aminoacid
sequence exhibitsaninteresting protein mosaic
architecture with tandem interaction domains containing regions ofgreatsimilarity
withinvasin,
a 103-kD adhesin of Yersiniae,adja-cent to an
EGF-like
domain,
amotif exhibited bynumerousmolecular
species
thatmediateadhesive
interactions
with cellsor extracellular matrix
proteins.
Invasin- and EGF-like do-mains have beenextensively investigated. Invasin,
aproduct of theINVlocus,
isaprotein
virulence determinant ofYersiniaethatpromotes
adhesion
of the bacterium andpenetration into
mammalian
phagocytic
andnonphagocytic
cells(21).
Severalreceptorsthatbind invasin have been
identified
andeachisamemberof theVLA
family
ofintegrin
celladhesion molecules thatexpressesa common#I
chain(22).
Thecarboxy-terminal
192
amino acids
of invasin contain theintegrin
binding
do-main(23),
eventhough
thisregion
doesnotcontain the tripep-tide sequenceArg-Gly-Asp (RGD),
a common motif forthebinding
site ofligands
withfB integrins (24).
Invasinand fibro-nectin bindtothe same, orclosely
located sitesona541
inte-grins, although
binding by
fibronectin is mediatedby
thetri-peptide
sequenceRGD,
whereas invasin binds with muchhigher
affinity
than does fibronectin(25).
The deducedse-quenceof WI-l cDNA
predicts
four 17-amino acidrepeatsintandem thatexhibit 88%
homology
withaportion
of invasinin the 192 amino acids oftheintegrin-binding
domain.Thetri-peptide
sequence RGDissimilarly
notpresent in WI- 1 cDNA. It remainspossible
that WI-1 ishomologous
to invasin inaregion
thatiscompletely
unrelatedtointegrin
binding.
How-ever, thehydrophilic,
highly exposed
ahelicesthatturnbackand forth on themselvespredictedinthe invasin-like domains of WI- I cDNA would make thisregion of theproteinsuitable forligand-receptorinteractions.
TheEGF-like domain inWI-I cDNAconsists ofa
single-copyhomologueofthe EGF repeat unit, which preserves many
of theCysorGlyresiduescharacteristic of the structure,and
particularlythe presence of twoantiparallel,3-strandsbetween
Cys 3 andCys4believedtocomprise the EGFreceptor
recogni-tion site (13). We recognize that only five of six consensus
cysteinesinthis motif are apparent in WI- I and that the
align-mentoftheseconservedresidues isnotprecise when compared
totheEGF consensus sequence.However, thespacing of con-served residuestypicallyvaries in EGF-likedomains so that at leastthreetypesofconsensus sequences havebeendescribed (13). When comparedtoother molecules
containing
EGF-like domains, WI-I shows thebest fit with the repeatsof lymph node homing receptor (26), uromodulin (27),nidogen
(28),andfibulin,each of which governs diverse cell-cellor
cell-ma-trix interactions.
This observation,
taken together with theclose proximityofthe EGF repeat and multipleinvasin-like
domains, wouldsupportthe notion that the
carboxy
terminusof surface exposed WI-I may promote adhesion of
Blasto-myces yeasts tohost cellsorextracellularmatrixproteins. Pre-liminaryexperiments indeed have shown thatWI-I functions
asan
adhesion-promoting
protein andmediates
thebinding
ofyeasts tomammalian cells.
Study
and further clarificationofthe role of WI-I in these interactive events may
provide
a clearerpictureof the molecularpathogenesisofblastomycosis.Acknowledgments
Wethank Robert DeMars and the members of his laboratory,
espe-ciallyStephanieCeman and Jean Petersen, fortechnical advice;John Marx and JamesStephens fortechnicalassistance;themedical media
staffattheWilliam S.MiddletonMemorialVeteransHospital for pho-tography andillustration;andEmilieEbel,Department ofPediatrics, University of Wisconsin HospitalandClinics, for preparationof the
manuscript.
The work was supported by National Institutes ofHealth grants
AI-00905andAI-31479, andby the VeteransAdministrationMedical
ResearchService.
References
1.Klein,B.S.,and J. M. Jones.1990.Isolation,purification,and
radiolabel-ing ofa novel 120-kDsurface protein onBlastomyces dermatitidisyeasts to detectantibodyininfected patients.J.Clin.Invest.85:152-161.
2.Klein,B.S.,P. M.Sondel,and J. M. Jones. 1992. WI-1, a novel 120 kD
surface proteinonBlastomyces dermatitidisyeasts,isatargetantigenof cell-me-diatedimmunityin humanBlastomycosis.Infect.Immun.60:4291-4300.
3.Fonzi,W. A., and P.S. Sypherd. 1985. Expression ofthe gene for ornithine decarboxylase ofSaccaromycescerevisiae inEscherichiacoli. Mol. Cell. BioL.
5:161-166.
4.Badley,J.E., G. A.Bishop,T.St.John, and J. A.Frelinger. 1988. A simple
rapidmethodforthepurification ofpolyA'RNA. Biotechniques. 6:114-116.
5. Dower,J. 1988. Transformation ofEscherichiacolito extremelyhigh effi-ciency by electroporation. Mol.Biol. Rep. 6:3-4.
6.Maniatis,T.,E. F.Fritsch,and J.Sambrook. 1989. MolecularCloning:A LaboratoryManual. 2nd ed.ColdSpring Harbor Laboratory, Cold Spring
Har-bor,NY.
7.Holden, D.W.,J. W.Kronstad,and S. A. Leong. 1989. Mutation ina
heat-regulatedhsp 70 gene ofUstilagomaydis. EMBO (Eur.Mol.Biol.Organ.)J.
8:1927-1934.
8. Devereux,J.,P.Haeberli,and 0. Smithies. 1984. A comprehensive set of sequenceanalysisprograms for the VAX.NucleicAcids Res. 12:387-395.
9.Laemmli,U. K. 1970.Cleavageof structuralproteinsduringtheassembly
of the headof bacteriophage T4. Nature (Lond.). 227:680-685.
10.Towbin, H., T.Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteinsfrom polyacrylamide gels to nitrocellulose sheets: procedure and some
applications.Proc.Natl.Acad. Sci. USA. 76:4350-4354.
11. Minden, P., and R.S. Farr. 1967. The ammonium sulfate method to
measureantigen-bindingcapacity. In Handbook of ExperimentalImmunology.
D. M.Weir,editor. F. A. Davis Co., Philadelphia. 463-492.
12. Isberg, R. R., D. L. Voorhis, andFalkow S. 1987. Identification ofinvasin: aprotein that allows enteric bacteria to penetrate cultured mammalian cells.Cell.
50:769-778.
13. Appella, E.,I. T. Weber, and F. Blasi. 1988. Structure and function of epidermal growth factor-like regions in proteins. FEBS (Fed. Eur. Biochem. Soc.) Lett. 231(l):1-4.
14. Altschul, S. F., W. Gish, W. Miller, E. W. Meyers, and D. J. Lipman. 1990.
Basiclocalalignmentsearch tool. J.Mol. Biol. 215:403-410.
15. Chou, P. Y.,and G.Fasman. 1978. Prediction of the secondary structure ofproteinsfrom their amino acid sequence. Adv.Enzymol. Relat.AreasMol.
Biol. 47:145-147.
16. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J.Mol.Biol. 157:105-132.
17. Kimmel, A. R., and S. L. Berger. 1987. Preparation of cDNA and the generation of cDNA libraries: Overview. In Guide to Molecular Cloning
Tech-niques. Methods inEnzymology. Vol. 152. S. L. Berger and A. R. Kimmel,
editors. Academic Press, Inc., San Diego, CA.
18.Bums, J. M., W. G. Shreffler, D. E. Rosman, P. R. Sleath, C. J. March, and S. G. Reed. 1992. Identificationand synthesisof a majorconservedantigenic epitope of Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA. 89:1239-1243.
19.Hopp, T. P. Protein surface analysis. 1986. Methods foridentifying anti-genic determinants and other interaction sites. J. Immunol. Methods. 88:1-18.
20.Deepe, G. S. Blastomycosis. 1989. In Immunology ofthe Fungal Diseases. R. A. Cox, editor. CRC Press, Inc., Boca Raton, FL. 139-164.
21.Isberg, R. R. 1991. Discrimination between intracellular uptake and sur-face adhesion of bacterial pathogens. Science (Wash. DC). 252:934-938.
22. Isberg, R. R. and J. M. Leong. 1990. Multiple ,1 chain integrins are receptorsforinvasin, a protein that promotes bacterial penetration into mamma-lian cells.Cell. 60:861-871.
23.Leong, J. M., R. S. Fournier, and R. R. Isberg. 1990. Identification ofthe integrin binding domain of the Yersiniapseudotuberculosis invasin protein. EMBO(Eur.Mol.Biol.Organ.) J. 9(6):1979-1989.
24.Hynes, R.0. 1992. Integrins: Versatility, modulation, andsignalingincell adhesion. Cell. 69:11-25.
25.Tran Van Nhieu, G., and R. R. Isberg. 1991. The Yersinia pseudotubercu-losisinvasin protein and human fibronectin bind to mutually exclusive sites on thea5#1integrinreceptor. J.Biol. Chem. 266(36):24367-24375.
26.Siegelman, M. H., M. Van de Rijn, and I. L. Weissman. 1989. Mouse
lymphnodehoming receptor cDNA clone encodes a glycoprotein revealing tan-deminteraction domains. Science (Wash. DC). 243:1165-1172.
27.Pennica, D., W. J. Kohr, W-J. Kuang, D. Glaister, B. B. Aggarwal, E. Y.
Chen, and D. V. Goeddel. 1987. Identificationof human uromodulin as the
Tamm-Horsfall urinary glycoprotein. Science (Wash. DC). 236:83-88. 28. Mann, K., R. Deutzmann, M. Aumailley, R. Timpl, L. Raimondi, Y. Yamada, T-C. Pan, D. Conway, and M-L. Chu. 1989. Amino acid sequence of mousenidogen, a multidomain basement membrane protein with binding activ-ityfor laminin, collagen IV and cells. EMBO (Eur.Mol. Biol. Organ.) J. 8(l):65-72.
29.Zaret, K. S. and F. Sherman. 1982. DNA sequence required for efficient